| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308304 | Kidney International | 2005 | 8 Pages |
Abstract
Combining results from 4 clinical trials, randomization to cinacalcet led to significant reductions in the risk of parathyroidectomy, fracture, and cardiovascular hospitalization, along with improvements in self-reported physical function and diminished pain. These data suggest that, in addition to its effects on PTH and mineral metabolism, cinacalcet had favorable effects on important clinical outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
John Cunningham, Mark Danese, Kurt Olson, Preston Klassen, Glenn M. Chertow,